Brazilian Strains of Toxoplasma Gondii Are Controlled by Azithromycin and Modulate Cytokine Production in Human Placental Explants

Overview

Journal J Biomed Sci

Publisher Biomed Central

Specialty Biology

Date 2019 Jan 23

PMID 30665403

Citations 7

Authors

Priscila Silva Franco

Paula Suellen Guimaraes Gois

Thadia Evelyn de Araujo

Rafaela Jose da Silva

Bellisa de Freitas Barbosa

Angelica de Oliveira Gomes

Francesca Ietta

Lara Affonso Dos Santos

Maria Celia Dos Santos

Jose Roberto Mineo

Eloisa Amalia Vieira Ferro

Affiliations

Soon will be listed here.

Abstract

Background: Toxoplasma gondii is a protozoan parasite that causes congenital toxoplasmosis by transplacental transmission. Parasite strains are genetically diverse and disease severity is related to the genotype. In Uberlândia city, Brazil, two virulent strains were isolated: TgChBrUD1 and TgChBrUD2. Congenital toxoplasmosis is more prevalent in South America compared to Europe, and more often associated with severe symptoms, usually as a result of infection with atypical strains.

Methods: Considering that T. gondii has shown high genetic diversity in Brazil, the effectiveness of traditional treatment may not be the same, as more virulent strains of atypical genotypes may predominate. Thus, the aim of this study were to evaluate the Brazilian strain infection rate in human villous explants and the azithromycin efficacy with regard to the control of these strains compared to traditional therapy. Villi were infected with RH, ME49, TgChBrUD1 or TgChBrUD2 strains and treated with azithromycin, spiramycin or a combination of pyrimethamine plus sulfadiazine. The villous viability was analyzed by LDH assay and morphological analysis. Parasite proliferation, as well as production of cytokines was analyzed by qPCR and ELISA, respectively. Statistical analysis was performed using the GraphPad Prism 5.0.

Results: The treatments were not toxic and TgChBrUD1 infected villi showed a higher parasite burden compared with others strains. Treatments significantly reduced the intracellular proliferation of T. gondii, regardless of the strain. TgChBrUD1-infected villi produced a larger amount of MIF, IL-6 and TGF-β1 compared with other infected villi. Azithromycin treatment increased MIF production by RH- or TgChBrUD2-infected villi, but in ME49- or TgChBrUD1-infected villi, the MIF production was not altered by treatment. On the other hand, azithromycin treatment induced lower IL-6 production by ME49- or TgChBrUD1-infected villi.

Conclusions: Azithromycin treatment was effective against T. gondii Brazilian strains compared with conventional treatment. Also, the TgChBrUD1 strain replicated more in villi and modulated important cytokines involved in parasite control, showing that different strains use different strategies to evade the host immune response and ensure their survival.

Citing Articles

Rapid genotyping of Toxoplasma gondii isolates via Nanopore-based multi-locus sequencing.

Koutsogiannis Z, Denny P AMB Express. 2024; 14(1):68.

PMID: 38844693 PMC: 11156620. DOI: 10.1186/s13568-024-01728-x.

P21 recombinant protein modulates infection in different experimental models of the human maternal-fetal interface.

de Souza G, Teixeira S, Fajardo Martinez A, Silva R, Luz L, de Lima Junior J Front Immunol. 2023; 14:1243480.

PMID: 37915581 PMC: 10617204. DOI: 10.3389/fimmu.2023.1243480.

Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.

de Lima Bessa G, Vitor R, Dos Santos Martins-Duarte E Parasitol Res. 2021; 120(9):3065-3076.

PMID: 34390383 DOI: 10.1007/s00436-021-07282-w.

Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants.

de Souza G, Silva R, Milian I, Rosini A, de Araujo T, Teixeira S Sci Rep. 2021; 11(1):12709.

PMID: 34135407 PMC: 8209052. DOI: 10.1038/s41598-021-92120-3.

In vivo and in vitro models show unexpected degrees of virulence among Toxoplasma gondii type II and III isolates from sheep.

Fernandez-Escobar M, Calero-Bernal R, Regidor-Cerrillo J, Vallejo R, Benavides J, Collantes-Fernandez E Vet Res. 2021; 52(1):82.

PMID: 34112256 PMC: 8194156. DOI: 10.1186/s13567-021-00953-7.

References

Grigg M, Ganatra J, Boothroyd J, Margolis T . Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001; 184(5):633-9. DOI: 10.1086/322800. View

Mordue D, Monroy F, La Regina M, Dinarello C, Sibley L . Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 2001; 167(8):4574-84. DOI: 10.4049/jimmunol.167.8.4574. View

Gilbert R, Gras L . Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 2003; 110(2):112-20. DOI: 10.1016/s1470-0328(02)02325-x. View

Nguyen T, Bigaignon G, Markine-Goriaynoff D, Heremans H, Nguyen T, Warnier G . Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon. J Med Microbiol. 2003; 52(Pt 10):869-876. DOI: 10.1099/jmm.0.04860-0. View

Calandra T, Roger T . Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003; 3(10):791-800. PMC: 7097468. DOI: 10.1038/nri1200. View

Montoya J, Liesenfeld O . Toxoplasmosis. Lancet. 2004; 363(9425):1965-76. DOI: 10.1016/S0140-6736(04)16412-X. View

Rubin B . Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med. 2004; 117 Suppl 9A:2S-4S. DOI: 10.1016/j.amjmed.2004.07.021. View

Tamaoki J, Kadota J, Takizawa H . Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004; 117 Suppl 9A:5S-11S. DOI: 10.1016/j.amjmed.2004.07.023. View

Saeij J, Boyle J, Boothroyd J . Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 2005; 21(10):476-81. DOI: 10.1016/j.pt.2005.08.001. View

10.

Sonda S, Hehl A . Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii. Trends Parasitol. 2005; 22(1):41-7. DOI: 10.1016/j.pt.2005.11.001. View

11.

Su C, Zhang X, Dubey J . Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int J Parasitol. 2006; 36(7):841-8. DOI: 10.1016/j.ijpara.2006.03.003. View

12.

Saeij J, Coller S, Boyle J, Jerome M, WHITE M, Boothroyd J . Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature. 2006; 445(7125):324-7. PMC: 2637441. DOI: 10.1038/nature05395. View

13.

Thiebaut R, Leproust S, Chene G, Gilbert R . Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007; 369(9556):115-22. DOI: 10.1016/S0140-6736(07)60072-5. View

14.

Pitsouni E, Iavazzo C, Athanasiou S, Falagas M . Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007; 30(3):213-21. DOI: 10.1016/j.ijantimicag.2007.04.015. View

15.

Pena H, Gennari S, Dubey J, Su C . Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 2007; 38(5):561-9. DOI: 10.1016/j.ijpara.2007.09.004. View

16.

Elsheikha H . Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2007; 122(4):335-53. DOI: 10.1016/j.puhe.2007.08.009. View

17.

Ferro E, Mineo J, Ietta F, Bechi N, Romagnoli R, Silva D . Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am J Pathol. 2008; 172(1):50-8. PMC: 2189627. DOI: 10.2353/ajpath.2008.070432. View

18.

Montoya J, Remington J . Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008; 47(4):554-66. DOI: 10.1086/590149. View

19.

Gilbert R, Freeman K, Lago E, Bahia-Oliveira L, Tan H, Wallon M . Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008; 2(8):e277. PMC: 2493041. DOI: 10.1371/journal.pntd.0000277. View

20.

Darde M . Toxoplasma gondii, "new" genotypes and virulence. Parasite. 2008; 15(3):366-71. DOI: 10.1051/parasite/2008153366. View